Real-World Safety Assessment of Early-Pregnancy Exposure to Baloxavir versus Oseltamivir: Pregnancy and Neonatal Outcomes
Drug Design, Development and Therapy · 2026-11 · Volume 20 · 1-13
DOI: 10.2147/dddt.s631636 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-11. Verfasst von Yue Chen und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chen, Y., Ye, S., Ma, Z., Zhang, M., Zhang, X., Wang, F., Sun, D., & Zheng, C. (2026). Real-World Safety Assessment of Early-Pregnancy Exposure to Baloxavir versus Oseltamivir: Pregnancy and Neonatal Outcomes. Drug Design, Development and Therapy, Volume 20, 1-13. https://doi.org/10.2147/dddt.s631636
Vancouver
Chen Y, Ye S, Ma Z, Zhang M, Zhang X, Wang F, et al. Real-World Safety Assessment of Early-Pregnancy Exposure to Baloxavir versus Oseltamivir: Pregnancy and Neonatal Outcomes. Drug Design, Development and Therapy. 2026;Volume 20:1-13. doi:10.2147/dddt.s631636
BibTeX
@article{Chen2026,
author = {Chen, Yue and Ye, Shuya and Ma, Zhiyuan and Zhang, Meng and Zhang, Xiao and Wang, Fengmei and Sun, Dongli and Zheng, Caihong},
title = {Real-World Safety Assessment of Early-Pregnancy Exposure to Baloxavir versus Oseltamivir: Pregnancy and Neonatal Outcomes},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--13},
doi = {10.2147/dddt.s631636}
}
EUVIMED